CareDx (CDNA) Cost of Revenue (2013 - 2026)

CareDx has disclosed Cost of Revenue across 14 years of filings, most recently posting $30.4 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $30.4 million, up 32.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $110.0 million (up 29.23% YoY), and the FY2025 annual result was $102.6 million, up 25.21% from the prior year.
• Cost of Revenue came in at $30.4 million for Q1 2026 at CareDx, down from $30.9 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $30.9 million in Q4 2025 to a low of $18.5 million in Q3 2023.
• The 5-year median for Cost of Revenue is $23.0 million (2025), against an average of $23.2 million.
• Across the five-year window, Cost of Revenue surged 49.81% in 2022 and slipped 19.74% in 2023, its largest moves.
• CareDx's Cost of Revenue stood at $23.7 million in 2022, then decreased by 12.43% to $20.7 million in 2023, then climbed by 2.96% to $21.3 million in 2024, then soared by 44.9% to $30.9 million in 2025, then fell by 1.78% to $30.4 million in 2026.
• The last three Cost of Revenue figures came in at $30.4 million (Q1 2026), $30.9 million (Q4 2025), and $24.4 million (Q3 2025), per Business Quant data.